Characterization of the neuraminidase genes from human influenza A viruses circulating in Iran from 2010 to 2015
| dc.contributor.author | Moasser, Elham | |
| dc.contributor.author | Behzadian, Farida | |
| dc.contributor.author | Moatari, Afagh | |
| dc.contributor.author | Fotouhi, Fatemeh | |
| dc.contributor.author | Zaraket, Hassan | |
| dc.contributor.department | Experimental Pathology, Microbiology, and Immunology | |
| dc.contributor.department | Specialized Clinical Programs and Services | |
| dc.contributor.department | Center for Infectious Diseases Research | |
| dc.contributor.faculty | Faculty of Medicine (FM) | |
| dc.contributor.institution | American University of Beirut | |
| dc.date.accessioned | 2025-01-24T11:38:57Z | |
| dc.date.available | 2025-01-24T11:38:57Z | |
| dc.date.issued | 2018 | |
| dc.description.abstract | Background: Characterization of influenza viruses is critical for detection of new emerging variants. Herein, we analyzed the genetic diversity and drug susceptibility of the neuraminidase gene (NAs) expressed by influenza A/H1N1pdm09 and A/H3N2 viruses circulating in Iran from 2010 to 2015. Methods: We genetically analyzed the NAs of 38 influenza A/H1N1pdm09 and 35 A/H3N2 isolates. Results: The Iranian A/H1N1pdm09 viruses belonged to seven genogroups/subgenogroups, with the dominant groups being genogroups 6B and 6C. The A/H3N2 isolates fell into six gneogroups/subgenogroups, with the dominant genogroups being 3C and 3C.2a. The most common mutations detected among the A/H1N1pdm09 viruses included N44S, V106I, N200S, and N248D. All H1N1pdm09 viruses were genetically susceptible to the NAIs. However, one A/H1N1pdm09 virus from the 2013–2014 season possessed an NA-S247N mutation, which reduces the susceptibility to oseltamivir. In case of H3N2, none of the analyzed Iranian strains carried a substitution that might affect its susceptibility to NAIs. Conclusion: The ongoing evolution of influenza viruses and the detect of influenza viruses with reduced susceptibility to NAIs warrants continuous monitoring of the circulating strains. © 2017, Springer-Verlag GmbH Austria. | |
| dc.identifier.doi | https://doi.org/10.1007/s00705-017-3603-y | |
| dc.identifier.eid | 2-s2.0-85041691897 | |
| dc.identifier.pmid | 29086107 | |
| dc.identifier.uri | http://hdl.handle.net/10938/29126 | |
| dc.language.iso | en | |
| dc.publisher | Springer-Verlag Wien | |
| dc.relation.ispartof | Archives of Virology | |
| dc.source | Scopus | |
| dc.subject | A/h1n1pdm09 | |
| dc.subject | A/h3n2 | |
| dc.subject | Antiviral resistance | |
| dc.subject | Influenza | |
| dc.subject | Iran | |
| dc.subject | Molecular genetic analysis | |
| dc.subject | Antiviral agents | |
| dc.subject | Humans | |
| dc.subject | Influenza a virus, h1n1 subtype | |
| dc.subject | Influenza a virus, h3n2 subtype | |
| dc.subject | Influenza, human | |
| dc.subject | Mutation, missense | |
| dc.subject | Neuraminidase | |
| dc.subject | Oseltamivir | |
| dc.subject | Phylogeny | |
| dc.subject | Viral proteins | |
| dc.subject | Antivirus agent | |
| dc.subject | Na protein, influenza a virus | |
| dc.subject | Sialidase | |
| dc.subject | Viral protein | |
| dc.subject | Antagonists and inhibitors | |
| dc.subject | Classification | |
| dc.subject | Drug effects | |
| dc.subject | Enzymology | |
| dc.subject | Genetics | |
| dc.subject | Human | |
| dc.subject | Influenza a virus (h1n1) | |
| dc.subject | Influenza a virus (h3n2) | |
| dc.subject | Metabolism | |
| dc.subject | Missense mutation | |
| dc.subject | Virology | |
| dc.title | Characterization of the neuraminidase genes from human influenza A viruses circulating in Iran from 2010 to 2015 | |
| dc.type | Article |
Files
Original bundle
1 - 1 of 1